 OXNARD, Calif.--BUSINESS WIRE--CURE Pharmaceutical Holding Corp. OTC: CURR, a vertically integrated drug delivery and product development company, reported its financial results and provided an operational update for the first quarter ended March 31, 2021. First Quarter 2021 and subsequent weeks highlights: Total revenue rose more than 400 to 1.5 million compared with a year ago and gross profit rose in line with revenue growth. Received approval for an Investigational New Drug IND appl 